Lot sizing in clinical trialsmanufacturing can save more than you think!
Testing different lot size scenarios can reduce manufacturing costs and drug waste. We explain how using real-world examples in this resource.
Fixed lot sizes are a problem
Treating lot sizes as fixed quantities results in high costs and unnecessary waste. When planners gain the ability to test different lot sizes, they can…
Adjust API/DS manufacturing strategy to deliver products when studies need it
Strategically manufacture smaller lots to reduce DP and IMP waste
Scale manufacturing to meet actual trial demand
Case study: Optimizing lot sizes saves 10.5M€
When N-SIDE optimized lot sizes for one top pharmaceutical company, they realized 10.5M€ in savings from reduced manufacturing costs (an 11% decrease). Download the whitepaper for details.